title: Non-cell autonomous effects of targeting inducible PGE2 synthesis during inflammation-associated colon carcinogenesis.
abstract: Microsomal PGE2 synthase-1 (mPGES-1), the terminal enzyme in the formation of inducible PGE2, represents a potential target for cancer chemoprevention. We have previously shown that genetic abrogation of mPGES-1 significantly suppresses tumorigenesis in two preclinical models of intestinal cancer. In this study, we examined the role of mPGES-1 during colon tumorigenesis in the presence of dextran sulfate sodium (DSS)-induced inflammatory microenvironment. Using Apc (Δ14/+) in which the mPGES-1 gene is either wild-type (D14:WT) or deleted (D14:KO), we report that mPGES-1 deficiency enhances sensitivity to acute mucosal injury. As a result of the increased epithelial damage, protection against adenoma formation is unexpectedly compromised in the D14:KO mice. Examining the DSS-induced acute injury, cryptal structures are formed within inflamed areas of colonic mucosa of both genotypes that display the hallmarks of early neoplasia. When acute epithelial injury is balanced by titration of DSS exposures, however, these small cryptal lesions progress rapidly to adenomas in the D14:WT mice. Given that mPGES-1 is highly expressed within the intestinal stroma under the inflammatory conditions of DSS-induced ulceration, we propose a complex and dual role for inducible PGE2 synthesis within the colonic mucosa. Our data suggest that inducible PGE2 is critical for the maintenance of an intact colonic epithelial barrier, while promoting epithelial regeneration. This function is exploited during neoplastic transformation in Apc (Δ14/+) mice as PGE2 contributes to the growth and expansion of the early initiated cryptal structures. Taken together, inducible PGE2 plays a complex role in inflammation-associated cancers that requires further analysis. Inducible PGE2 production by mPGES-1 is critical for the colonic mucosal homeostasis. This function is exploited in the presence of the neoplastic transformation in Apc (Δ14/+) mice as PGE2 contributes to the growth and expansion of the early cryptal structures.
authors: Center for Molecular Medicine, University of Connecticut Health Center, Farmington, CT, USA, Inserm, U1016, département endocrinologie métabolisme et cancer, Institut Cochin, Paris, France and The University of Arizona Cancer Center, Department of Molecular and Cell Biology, Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA. Tucson, AZ, USA.
authors: Masako
authors: M
authors: Nakanishi
authors: Center for Molecular Medicine, University of Connecticut Health Center, Farmington, CT, USA, Inserm, U1016, département endocrinologie métabolisme et cancer, Institut Cochin, Paris, France and.
authors: Christine
authors: C
authors: Perret
authors: The University of Arizona Cancer Center, Department of Molecular and Cell Biology, Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA. Tucson, AZ, USA.
authors: Emmanuelle J
authors: EJ
authors: Meuillet
authors: Center for Molecular Medicine, University of Connecticut Health Center, Farmington, CT, USA, Inserm, U1016, département endocrinologie métabolisme et cancer, Institut Cochin, Paris, France and The University of Arizona Cancer Center, Department of Molecular and Cell Biology, Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA. Tucson, AZ, USA Rosenberg@uchc.edu.
authors: Daniel W
authors: DW
authors: Rosenberg
mesh_terms: D000236:Adenoma / Q000139:chemically induced / Q000235:genetics*; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000235:genetics*; D003106:Colon / Q000473:pathology; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000235:genetics*; D016264:Dextran Sulfate; D015232:Dinoprostone / Q000096:biosynthesis* / Q000235:genetics; D005260:Female; D017491:Genes, APC; D020022:Genetic Predisposition to Disease; D007249:Inflammation / Q000139:chemically induced; D007413:Intestinal Mucosa / Q000473:pathology; D019746:Intramolecular Oxidoreductases / Q000235:genetics*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D000071876:Prostaglandin-E Synthases
chemical_list: D016264:Dextran Sulfate; D019746:Intramolecular Oxidoreductases; D000071876:Prostaglandin-E Synthases; C000605865:Ptges protein, mouse; D015232:Dinoprostone
references: Nature. 2009 Jan 29;457(7229):608-11
references: 19092804
references: Gastroenterology. 2012 Jul;143(1):110-21.e10
references: 22465430
references: PLoS One. 2009;4(6):e6073
references: 19562033
references: Cancer Sci. 2009 Nov;100(11):2022-7
references: 19694754
references: Prostaglandins Other Lipid Mediat. 2009 Nov;90(1-2):21-5
references: 19559811
references: Dig Dis Sci. 2010 Feb;55(2):226-32
references: 19924534
references: Oncogene. 2010 Feb 11;29(6):781-8
references: 19946329
references: Biochimie. 2010 Jun;92(6):651-9
references: 20159030
references: Biochimie. 2010 Jun;92(6):660-4
references: 20159031
references: Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20027-32
references: 21041628
references: Gastroenterology. 2012 Jul;143(1):19-22
references: 22626500
references: Semin Immunopathol. 2013 Mar;35(2):123-37
references: 22996682
references: Clin Exp Rheumatol. 2001 Nov-Dec;19(6 Suppl 25):S31-6
references: 11695249
references: Gut. 2001 Apr;48(4):526-35
references: 11247898
references: Digestion. 2001;63 Suppl 1:73-80
references: 11173914
references: J Clin Invest. 2002 Apr;109(7):883-93
references: 11927615
references: Scand J Immunol. 2002 Jul;56(1):66-75
references: 12100473
references: Nat Rev Mol Cell Biol. 2003 Sep;4(9):721-32
references: 14506475
references: Gastroenterology. 2004 Feb;126(2):451-9
references: 14762782
references: Gastroenterology. 1979 Sep;77(3):433-43
references: 456839
references: Cancer Res. 1988 Aug 1;48(15):4399-404
references: 3390835
references: J Lab Clin Med. 1993 Nov;122(5):518-23
references: 8228569
references: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
references: 10318916
references: Gastroenterol Clin North Am. 1999 Jun;28(2):459-77, x
references: 10372277
references: Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7220-5
references: 10377395
references: Prostaglandins Other Lipid Mediat. 2013 Oct;106:99-105
references: 23624019
references: Biomed Pharmacother. 2014 Feb;68(1):71-7
references: 24291175
references: Carcinogenesis. 2014 Mar;35(3):606-12
references: 24336194
references: Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:26-36
references: 25460828
references: Carcinogenesis. 2013 May;34(5):1150-7
references: 23349017
references: Lab Invest. 2004 Dec;84(12):1619-30
references: 15502862
references: N Engl J Med. 2005 Mar 17;352(11):1092-102
references: 15713943
references: Int J Cancer. 2006 Jan 1;118(1):25-34
references: 16049979
references: Cancer Res. 2006 Jan 15;66(2):846-55
references: 16424017
references: Aliment Pharmacol Ther. 2006 Apr 15;23(8):1097-104
references: 16611269
references: J Clin Invest. 2006 May;116(5):1391-9
references: 16614756
references: Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14507-12
references: 16973753
references: Biochem Pharmacol. 2006 Nov 30;72(11):1605-21
references: 16889756
references: Lancet. 2007 May 12;369(9573):1603-13
references: 17499602
references: Circulation. 2008 Apr 1;117(13):1701-10
references: 18347209
references: Gastroenterology. 2008 Apr;134(4):1224-37
references: 18395100
references: Cancer Res. 2008 May 1;68(9):3251-9
references: 18451151
references: Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1558-61
references: 18628408
references: J Pharmacol Sci. 2010;114(3):248-61
references: 21041985
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Drug Des Devel Ther. 2011;5:185-210
references: 21552489
references: World J Gastroenterol. 2011 May 7;17(17):2161-71
references: 21633524
references: Cancer Prev Res (Phila). 2011 Aug;4(8):1198-208
references: 21576350
references: Cancer Prev Res (Phila). 2011 Nov;4(11):1728-35
references: 21778329
references: J Biomed Biotechnol. 2012;2012:718617
references: 22665990
references: Nat Rev Clin Oncol. 2012 May;9(5):259-67
references: 22473097
references: Oncogene. 2012 Jun 14;31(24):2943-52
references: 21986945
references: Carcinogenesis. 2009 Feb;30(2):183-96
references: 19037092